Registry
OtherThis prospective registry and biorepository will collect clinical data and specimens for research in childhood cancer predisposition.
NCT Number: NCT04511806
The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives.
The central hypothesis is that studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early detection, and cancer prevention, which will collectively contribute to improving care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Interested in participating?
Request InfoAll sexes
Observational
Hospital for Sick Children, Toronto, Ontario, Canada
The CCPS is designed as a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a CPS and their relatives. The investigators plan to:
The study will enroll approximately 350 Children and 700 Relatives per year. The investigators plan to collect demographic and diagnostic data at enrollment. Longitudinal follow-up will be performed at least annually.
The CCPS includes the establishment of a biorepository, with a hub and spoke structure, with a central repository at Emory University/Children's Healthcare of Atlanta for prospective collection of some tissues, linked to local biorepositories at participating institutions. Information about inventory of tumor specimens already banked locally will be available in the database, along with reference to existing genomic studies of the tumor, such that investigators may identify and request such tissue or data for specific studies, subject to approval of the CCPS Scientific Committee.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Primary Subjects must meet all of the below criteria to be eligible for enrollment:
Affected Parents must meet all of the following criteria to be eligible for enrollment:
Adult Affected Siblings must meet all of the following criteria to be eligible for enrollment:
Unaffected Parents and Siblings must meet all of the following criteria to be eligible for enrollment
Affected Family Members must meet all of the following criteria to be eligible for enrollment:
More than one child from a Primary Family Unit may be a Primary Subject. An Unaffected Sibling may be reclassified as a Primary Subject if diagnosed with a CPS during childhood.
Exclusion criteria
This prospective registry and biorepository will collect clinical data and specimens for research in childhood cancer predisposition.
Time frame: Up to 10 years
This multicenter registry and biorepository will be developed with the purpose of studying individuals at high risk for childhood cancer to improve care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Time frame: Up to 10 years
To define the natural history of disease in children with CPS.
Time frame: Up to 10 years
Evaluate the clinical impact and effectiveness of standard and emerging tumor surveillance strategies to improve care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Contact information is provided by the study sponsor or research team.
Emory University
Other
Acronym: CCPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07727694
Neoplasms, Pediatric Cancer
Antwerp, Belgium
View Trial DetailsNCT06458036
Cancer, Cancer, Thyroid
San Francisco, California, United States
View Trial DetailsNCT04948619
Neoplasms, Pediatric Cancer
Charlotte, North Carolina, United States
View Trial DetailsNCT05058508
Behavior, Motor Activity
Charlotte, North Carolina, United States
View Trial Details